| Product Code: ETC10689327 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Oncology Companion Diagnostics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Oncology Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Oncology Companion Diagnostics Market - Industry Life Cycle |
3.4 Thailand Oncology Companion Diagnostics Market - Porter's Five Forces |
3.5 Thailand Oncology Companion Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Thailand Oncology Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Thailand Oncology Companion Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Thailand Oncology Companion Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
4 Thailand Oncology Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Thailand |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Technological advancements in companion diagnostics |
4.3 Market Restraints |
4.3.1 High costs associated with companion diagnostics |
4.3.2 Limited awareness among healthcare professionals and patients |
4.3.3 Regulatory challenges in the approval process for companion diagnostics |
5 Thailand Oncology Companion Diagnostics Market Trends |
6 Thailand Oncology Companion Diagnostics Market, By Types |
6.1 Thailand Oncology Companion Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By NGS-Based, 2021 - 2031F |
6.1.5 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By IHC-Based, 2021 - 2031F |
6.1.6 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By FISH-Based, 2021 - 2031F |
6.2 Thailand Oncology Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.5 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.3 Thailand Oncology Companion Diagnostics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.3.4 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.3.5 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Thailand Oncology Companion Diagnostics Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Thailand Oncology Companion Diagnostics Market Revenues & Volume, By Urine, 2021 - 2031F |
7 Thailand Oncology Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Thailand Oncology Companion Diagnostics Market Export to Major Countries |
7.2 Thailand Oncology Companion Diagnostics Market Imports from Major Countries |
8 Thailand Oncology Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics in oncology treatment |
8.2 Number of collaborations between diagnostic companies and healthcare providers |
8.3 Rate of reimbursement for companion diagnostics by insurance providers |
9 Thailand Oncology Companion Diagnostics Market - Opportunity Assessment |
9.1 Thailand Oncology Companion Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Thailand Oncology Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Thailand Oncology Companion Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Thailand Oncology Companion Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10 Thailand Oncology Companion Diagnostics Market - Competitive Landscape |
10.1 Thailand Oncology Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Thailand Oncology Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here